Corporate & Investor Presentation
Who we are / what we do
•
●
●
Listed on NYSE & ASX, ~$29B market cap
World-leading digital health company with over 12 million
100% cloud-connectable devices
- ~14 million patients in AirView monitoring ecosystem
-
More than 95 million patient accounts in out-of-hospital care network
Innovative designer and manufacturer of award-winning devices and
cloud-based software solutions
.
-
– Diagnose, treat, and manage sleep apnea, chronic obstructive pulmonary disease,
and other respiratory conditions
Products and solutions designed to improve patient quality of life, reduce
impact of chronic disease, and lower healthcare costs
Cloud-based software solutions and devices designed to provide connected care,
improving patient outcomes and efficiencies for healthcare providers
-
Tools that allow fewer people to manage more patients
- Empower patients to track own health outcomes
4 2020 ResMed | Corporate & Investor Presentation - updated 05AUG20
Med my Air
Au
85
1:00 points
Excellent resultsex
A
ResMedView entire presentation